The latest cancer drugs news
Browsing: Cancer Drug News
T cell revival correlates with lung cancer response to PD-1 immunotherapy
In lung cancer patients who were taking immunotherapy drugs targeting the PD-1 pathway, testing for…
SIRT better tolerated than sorafenib, but doesn’t increase overall survival in HCC
Results of the SARAH trial presented today demonstrate that SIRT resulted in median overall survival…
Nivolumab produces durable responses & long-term survival in severe liver cancer patients
Results from the CheckMate 040 study found that nivolumab, an immuno-oncology drug which acts by…
Scientists identify new way of attacking breast cancer
Scientists have discovered a brand new way of attacking breast cancer that could lead to…
A one-two punch for pancreatic cancer: ‘softening’ tumours before chemo
Meredith Ross, UNSW A two-step approach has had promising results in the treatment of pancreatic cancer,…
New immunotherapy combination shows promise for patients with advanced melanoma
Treatment with a combination of ipilimumab (Yervoy) and Coxsackievirus A21 (CVA21; Cavatak) led to durable…
AACR 2017: Combination of nivolumab and ipilimumab improved overall survival for advanced melanoma patients
Among patients with advanced melanoma, those who received both nivolumab (Opdivo) and ipilimumab (Yervoy) had…
Link between common prostate cancer treatment, dementia detailed in new study
A new analysis of patients who have undergone treatment for prostate cancer shows a connection…
High doses of vitamin C to improve cancer treatment passes human safety trial
Clinical trials found that it is safe to regularly infuse brain and lung cancer patients…
AACR 2017: Regular aspirin use is associated with lower cancer mortality
Long-term, regular aspirin use was associated with reduced risk of death from several different kinds…